Home › Calculator › NURPF Dividend Calculator 2026
NURPF Dividend DRIP Calculator 2026
12.42% YieldHealthcareNeuren Pharmaceuticals Limited · OTC
Price: $16.10 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NURPF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NURPF snowball 📈
$10,000 in NURPF → $11.56M in 10 years · $116.89/month
About Neuren Pharmaceuticals Limited (NURPF) — Dividend Analysis 2026
Neuren Pharmaceuticals Limited is a biopharmaceutical company specializing in the development of treatments for neurological conditions. Their leading therapeutic compound, trofinetide, is currently undergoing pivotal (Phase III) clinical trials for Rett syndrome, and has also successfully completed Phase II trials targeting Fragile X syndrome. The company is also progressing NNZ-2591, which has finished its initial human trials (Phase I) for a spectrum of rare neurodevelopmental disorders, including Phelan-McDermid, Angelman, Pitt Hopkins, and Prader-Willi syndromes. In addition to its drug pipeline, Neuren provides development-related services and possesses investments in loan-backed shares. The firm was established in 2001 and operates from its base in Camberwell, Australia.
Compare NURPF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NURPF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NURPF position with:
🌍 NURPF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NURPF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 12.42% | 9.62% | $1,242 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 10.56% | 7.76% | $1,056 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 9.94% | 7.14% | $994 / yr |
| 🇬🇧 UK ISA | 0% | 12.42% | 9.62% | $1,242 / yr |
| 🇬🇧 UK Taxable | 8.75% | 11.33% | 8.53% | $1,133 / yr |
| 🇨🇦 TFSA | 0% | 12.42% | 9.62% | $1,242 / yr |
| 🇨🇦 CA Taxable | 25% | 9.31% | 6.51% | $932 / yr |
| 🇦🇺 Super (pension) | 15% | 10.56% | 7.76% | $1,056 / yr |
| 🇦🇺 AU Taxable | 30% | 8.69% | 5.89% | $869 / yr |
| 🇩🇪 DE Taxable | 26.375% | 9.14% | 6.34% | $914 / yr |
| 🇫🇷 FR Taxable | 30% | 8.69% | 5.89% | $869 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NURPF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NURPF Dividend Payment Schedule
NURPF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NURPF vs Healthcare Benchmarks
How NURPF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NURPF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NURPF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NURPF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Neuren Pharmaceuticals Limited (NURPF) is currently trading at $16.10, 5% below its 52-week high. The current dividend yield is 12.42% based on an annual payout of $2.00 per share.
NURPF (Neuren Pharmaceuticals Limited) — 12.42% Dividend Yield Analysis
Neuren Pharmaceuticals Limited (NURPF) is a healthcare stock currently trading at $16.10 with a dividend yield of 12.42%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (12.42%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.